These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20566220)

  • 21. Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs.
    Pérez-Martín E; Grau-Roma L; Argilaguet JM; Nofrarías M; Escribano JM; Gómez-Sebastián S; Segalés J; Rodríguez F
    J Virol Methods; 2008 Dec; 154(1-2):167-74. PubMed ID: 18773923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
    Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
    Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2.
    Opriessnig T; Thacker EL; Yu S; Fenaux M; Meng XJ; Halbur PG
    Vet Pathol; 2004 Nov; 41(6):624-40. PubMed ID: 15557072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porcine reproductive and respiratory syndrome virus (PRRSV) influences infection dynamics of porcine circovirus type 2 (PCV2) subtypes PCV2a and PCV2b by prolonging PCV2 viremia and shedding.
    Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Meng XJ; Halbur PG; Opriessnig T
    Vet Microbiol; 2011 Sep; 152(3-4):235-46. PubMed ID: 21641124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
    Opriessnig T; Gerber PF; Xiao CT; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2014 Jul; 32(34):4342-8. PubMed ID: 24929119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus.
    Allan GM; Kennedy S; McNeilly F; Foster JC; Ellis JA; Krakowka SJ; Meehan BM; Adair BM
    J Comp Pathol; 1999 Jul; 121(1):1-11. PubMed ID: 10373289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine mRNA expression profiles in peripheral blood mononuclear cells from piglets experimentally co-infected with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
    Shi KC; Guo X; Ge XN; Liu Q; Yang HC
    Vet Microbiol; 2010 Jan; 140(1-2):155-60. PubMed ID: 19854008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular lesions in pigs experimentally infected with porcine circovirus type 2 serogroup B.
    Langohr IM; Stevenson GW; Nelson EA; Lenz SD; HogenEsch H; Wei H; Pogranichniy RM
    Vet Pathol; 2010 Jan; 47(1):140-7. PubMed ID: 20080495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproduction of lesions of postweaning multisystemic wasting syndrome by infection of conventional pigs with porcine circovirus type 2 alone or in combination with porcine parvovirus.
    Kennedy S; Moffett D; McNeilly F; Meehan B; Ellis J; Krakowka S; Allan GM
    J Comp Pathol; 2000 Jan; 122(1):9-24. PubMed ID: 10627387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excessive porcine circovirus type 2 antibody titres may trigger the development of porcine dermatitis and nephropathy syndrome: a case-control study.
    Wellenberg GJ; Stockhofe-Zurwieden N; de Jong MF; Boersma WJ; Elbers AR
    Vet Microbiol; 2004 Apr; 99(3-4):203-14. PubMed ID: 15066723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
    Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
    Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual heterologous porcine circovirus genogroup 2a/2b infection induces severe disease in germ-free pigs.
    Harding JC; Ellis JA; McIntosh KA; Krakowka S
    Vet Microbiol; 2010 Oct; 145(3-4):209-19. PubMed ID: 20409649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein.
    Guo LJ; Fu YJ; Huang LP; Wang YP; Wei YW; Wu HL; Liu CM
    Vaccine; 2015 Jul; 33(31):3752-7. PubMed ID: 26051516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
    Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in peripheral blood leukocyte subpopulations in piglets co-infected experimentally with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
    Shi K; Li H; Guo X; Ge X; Jia H; Zheng S; Yang H
    Vet Microbiol; 2008 Jun; 129(3-4):367-77. PubMed ID: 18164875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study on the severity and relevance of porcine circovirus type 2 infections in Dutch fattening pigs with respiratory diseases.
    Wellenberg GJ; Bouwkamp FT; Wolf PJ; Swart WA; Mombarg MJ; de Gee AL
    Vet Microbiol; 2010 May; 142(3-4):217-24. PubMed ID: 19913367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.
    Fort M; Sibila M; Pérez-Martín E; Nofrarías M; Mateu E; Segalés J
    Vaccine; 2009 Jun; 27(30):4031-7. PubMed ID: 19379787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs.
    Fort M; Olvera A; Sibila M; Segalés J; Mateu E
    Vet Microbiol; 2007 Dec; 125(3-4):244-55. PubMed ID: 17611048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
    Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.